Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma
Enrico N De Toni1, Daniel Roessler2
1Department of Medicine II, University Hospital, LMU Munich, Munich, Germany enrico.detoni@med.uni-muenchen.de.
Gut
|February 14, 2020
Abstract
No abstract available in PubMed .
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.3K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
984
